53 related articles for article (PubMed ID: 16094635)
1. Emerging role for SRC family kinases in junction dynamics during spermatogenesis.
Xiao X; Yang Y; Mao B; Cheng CY; Ni Y
Reproduction; 2019 Mar; 157(3):R85-R94. PubMed ID: 30608903
[TBL] [Abstract][Full Text] [Related]
2. Exploring antiproliferative activities and kinase profile of ortho-substituted N-(4-(2-(benzylamino)-2-oxoethyl)phenyl)benzamides.
Muhammad YA; Omar AM; Ahmed F; Khayat MT; Malebari AM; Ibrahim SM; Mass SA; Elfaky MA; El-Araby ME
Chem Biol Drug Des; 2024 Jan; 103(1):e14379. PubMed ID: 37873688
[TBL] [Abstract][Full Text] [Related]
3. The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.
Jacobsen AV; Pierotti CL; Lowes KN; Au AE; Zhang Y; Etemadi N; Fitzgibbon C; Kersten WJA; Samson AL; van Delft MF; Huang DCS; Sabroux HJ; Lessene G; Silke J; Murphy JM
Cell Death Dis; 2022 Apr; 13(4):291. PubMed ID: 35365636
[TBL] [Abstract][Full Text] [Related]
4. Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance.
Rausch M; Weiss A; Zoetemelk M; Piersma SR; Jimenez CR; van Beijnum JR; Nowak-Sliwinska P
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33126775
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications.
Jin W
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32456226
[TBL] [Abstract][Full Text] [Related]
6. Molecular Determinants of Cancer Therapy Resistance to HDAC Inhibitor-Induced Autophagy.
Mrakovcic M; Fröhlich LF
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31906235
[TBL] [Abstract][Full Text] [Related]
7. p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death.
Mrakovcic M; Kleinheinz J; Fröhlich LF
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096697
[TBL] [Abstract][Full Text] [Related]
8. Impact of butyrate on PKM2 and HSP90β expression in human colon tissues of different transformation stages: a comparison of gene and protein data.
Jahns F; Wilhelm A; Greulich KO; Mothes H; Radeva M; Wölfert A; Glei M
Genes Nutr; 2012 Apr; 7(2):235-46. PubMed ID: 22009386
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular mechanisms of CLL: novel therapeutic approaches.
Pleyer L; Egle A; Hartmann TN; Greil R
Nat Rev Clin Oncol; 2009 Jul; 6(7):405-18. PubMed ID: 19488076
[TBL] [Abstract][Full Text] [Related]
10. Targeting SRC and epidermal growth factor receptor in colorectal cancer: rationale and progress into the clinic.
Kopetz S
Gastrointest Cancer Res; 2007; 1(4 Suppl 2):S37-41. PubMed ID: 19360146
[TBL] [Abstract][Full Text] [Related]
11. Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells.
Emaduddin M; Bicknell DC; Bodmer WF; Feller SM
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2358-62. PubMed ID: 18258742
[TBL] [Abstract][Full Text] [Related]
12. Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cells.
Barraclough J; Hodgkinson C; Hogg A; Dive C; Welman A
Neoplasia; 2007 Sep; 9(9):745-54. PubMed ID: 17898870
[TBL] [Abstract][Full Text] [Related]
13. Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells.
Milani L; Gupta M; Andersen M; Dhar S; Fryknäs M; Isaksson A; Larsson R; Syvänen AC
Nucleic Acids Res; 2007; 35(5):e34. PubMed ID: 17267408
[TBL] [Abstract][Full Text] [Related]
14. Activation of c-Yes in hepatocellular carcinoma: a preliminary study.
Feng H; Masaki T; Nonomura T; Morishita A; Jian G; Nakai S; Deguchi A; Uchida N; Himoto T; Iwama H; Usuki H; Wakabayashi H; Izuishi K; Yoshiji H; Kurokohchi K; Kuriyama S
World J Gastroenterol; 2006 Sep; 12(35):5743-5. PubMed ID: 17007035
[No Abstract] [Full Text] [Related]
15. Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells.
Hirsch CL; Smith-Windsor EL; Bonham K
Int J Cancer; 2006 Feb; 118(3):547-54. PubMed ID: 16094635
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitous and tissue specific promoters of the human SRC gene are repressed by inhibitors of histone deacetylases.
Kostyniuk CL; Dehm SM; Batten D; Bonham K
Oncogene; 2002 Sep; 21(41):6340-7. PubMed ID: 12214274
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
19. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function.
Brickell PM
Crit Rev Oncog; 1992; 3(4):401-46. PubMed ID: 1384720
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
